Back to Newsroom
Back to Newsroom

ACAS, CLDX, GEVO and GPOR added to NASDAQ Active Stock Watch List at EPR

Wednesday, 06 November 2013 09:27 AM

Topic:

New York, NY - (ACCESSWIRE) - 11/06/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding American Capital, Ltd. (NASDAQ:ACAS), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Gevo, Inc. (NASDAQ:GEVO), and Gulfport Energy Corp. (NASDAQ:GPOR) 

American Capital, Ltd. (NASDAQ:ACAS) is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments closed down in its previous session (-0.73%) on 3,223,145 shares traded after American Capital Reported Net Operating Income Before Income Taxes Of $0.16 Per Diluted Share, Net Loss Of $1 Million And Net Asset Value Per Share Of $19.54. American Capital, Ltd. (NASDAQ:ACAS) is currently down (-6.69%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about American Capital, Ltd. (NASDAQ:ACAS)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ACAS&SubId=AW 

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed down in its previous session (-0.51%) on 2,240,830 shares traded after Celldex Therapeutics has developed a deep pipeline of therapeutic candidates based on the philosophy of immunotherapy. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-41.63%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.  

To find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CLDX&SubId=AW 

Gevo, Inc. (NASDAQ:GEVO) a renewable chemicals and biofuels company that focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks closed down in its previous session (-3.49%) on 428,863 shares traded after Gevo Reported Third Quarter 2013 Financial Results. Gevo, Inc. (NASDAQ:GEVO) is currently down (-40%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Gevo, Inc. (NASDAQ:GEVO) 

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=GEVO&SubId=AW 

Gulfport Energy Corp. (NASDAQ:GPOR) a company that engages in the exploration, development, and production of oil and natural gas properties closed down in its previous session (-0.41%) on 2,993,974 shares traded after Gulfport Energy Corporation Reported Third Quarter 2013 Results. Gulfport Energy Corp. (NASDAQ:GPOR) is currently down (-14.87%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Gulfport Energy Corp. (NASDAQ:GPOR)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=GPOR&SubId=AW 

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com 

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures. 

Contact Info:
Equity Profile Report
[email protected]
Topic:
Back to newsroom
Back to Newsroom
Share by: